Baxter, L; Bryant, J; Cave, CB; Milne, R; (2007) Recombinant growth hormone for children and adolescents with Turner syndrome. The Cochrane database of systematic reviews (1). CD003887. ISSN 1469-493X DOI: https://doi.org/10.1002/14651858.CD003887.pub2

Blau, J; Hoestlandt, C; D Clark, A; Baxter, L; Felix Garcia, AG; Mounaud, B; Mosina, L; (2014) Strengthening national decision-making on immunization by building capacity for economic evaluation: Implementing ProVac in Europe. Vaccine, 33 Sup. A34-9. ISSN 0264-410X DOI: https://doi.org/10.1016/j.vaccine.2014.12.073 Full text not available from this repository.

Bryant, J; Baxter, L; Cave, CB; Milne, R; (2007) Recombinant growth hormone for idiopathic short stature in children and adolescents. The Cochrane database of systematic reviews (3). CD004440. ISSN 1469-493X DOI: https://doi.org/10.1002/14651858.CD004440.pub2

Bryant, J; Baxter, L; Hird, S; (2009) Non-occupational postexposure prophylaxis for HIV: a systematic review. Health technology assessment (Winchester, England), 13 (14). iii, ix-x, 1-60. ISSN 1366-5278 DOI: https://doi.org/10.3310/hta13140

Bryant, J; Picot, J; Baxter, L; Levitt, G; Sullivan, I; Clegg, A; (2007) Use of cardiac markers to assess the toxic effects of anthracyclines given to children with cancer: a systematic review. European journal of cancer (Oxford, England, 43 (13). pp. 1959-66. ISSN 0959-8049 DOI: https://doi.org/10.1016/j.ejca.2007.06.012 Full text not available from this repository.

Bryant, J; Picot, J; Baxter, L; Levitt, G; Sullivan, I; Clegg, A; (2007) Clinical and cost-effectiveness of cardioprotection against the toxic effects of anthracyclines given to children with cancer: a systematic review. British journal of cancer, 96 (2). pp. 226-30. ISSN 0007-0920 DOI: https://doi.org/10.1038/sj.bjc.6603562

Bryant, J; Picot, J; Levitt, G; Sullivan, I; Baxter, L; Clegg, A; (2007) Cardioprotection against the toxic effects of anthracyclines given to children with cancer: a systematic review. Health technology assessment (Winchester, England), 11 (27). iii, ix-x, 1-84. ISSN 1366-5278 DOI: https://doi.org/10.3310/hta11270

Hartwell, D; Jones, J; Baxter, L; Shepherd, J; (2012) Shortened peginterferon and ribavirin treatment for chronic hepatitis C. International journal of technology assessment in health care, 28 (4). pp. 398-406. ISSN 0266-4623 DOI: https://doi.org/10.1017/S0266462312000463

Hartwell, D; Jones, J; Baxter, L; Shepherd, J; (2011) Peginterferon alfa and ribavirin for chronic hepatitis C in patients eligible for shortened treatment, re-treatment or in HCV/HIV co-infection: a systematic review and economic evaluation. Health technology assessment (Winchester, England), 15 (17). i-xii, 1-210. ISSN 1366-5278 DOI: https://doi.org/10.3310/hta15170

Jauregui, B; Garcia, AG; Bess Janusz, C; Blau, J; Munier, A; Atherly, D; Mvundura, M; Hajjeh, R; Lopman, B; Clark, AD; +4 more... Baxter, L; Hutubessy, R; de Quadros, C; Andrus, JK; (2014) Evidence-based decision-making for vaccine introductions: Overview of the ProVac International Working Group's experience. Vaccine, 33 Sup. A28-33. ISSN 0264-410X DOI: https://doi.org/10.1016/j.vaccine.2014.10.090 Full text not available from this repository.

Javanbakht, M; Moradi-Lakeh, M; Yaghoubi, M; Esteghamati, A; Mansour Ghanaie, R; Mahmoudi, S; Shamshiri, AR; Zahraei, SM; Baxter, L; Shakerian, S; +4 more... Chaudhri, I; Fleming, JA; Munier, A; Baradaran, HR; (2014) Cost-effectiveness analysis of the introduction of rotavirus vaccine in Iran. Vaccine, 33 Sup. A192-200. ISSN 0264-410X DOI: https://doi.org/10.1016/j.vaccine.2014.12.035 Full text not available from this repository.

Jones, J; Shepherd, J; Baxter, L; Gospodarevskaya, E; Hartwell, D; Harris, P; Price, A; (2009) Adefovir dipivoxil and pegylated interferon alpha for the treatment of chronic hepatitis B: an updated systematic review and economic evaluation. Health technology assessment (Winchester, England), 13 (35). 1-172, iii. ISSN 1366-5278 DOI: https://doi.org/10.3310/hta13350

Picot, J; Jones, J; Colquitt, JL; Gospodarevskaya, E; Loveman, E; Baxter, L; Clegg, AJ; (2009) The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health technology assessment (Winchester, England), 13 (41). 1-190, 215-357, iii-iv. ISSN 1366-5278 DOI: https://doi.org/10.3310/hta13410

Shepherd, J; Jones, J; Frampton, G; Bryant, J; Baxter, L; Cooper, K; (2013) Clinical effectiveness and cost-effectiveness of depth of anaesthesia monitoring (E-Entropy, Bispectral Index and Narcotrend): a systematic review and economic evaluation. Health technology assessment (Winchester, England), 17 (34). pp. 1-264. ISSN 1366-5278 DOI: https://doi.org/10.3310/hta17340

Sibak, M; Moussa, I; El-Tantawy, N; Badr, S; Chaudhri, I; Allam, E; Baxter, L; Abo Freikha, S; Hoestlandt, C; Lara, C; +2 more... Hajjeh, R; Munier, A; (2014) Cost-effectiveness analysis of the introduction of the pneumococcal conjugate vaccine (PCV-13) in the Egyptian national immunization program, 2013. Vaccine, 33 Sup. A182-91. ISSN 0264-410X DOI: https://doi.org/10.1016/j.vaccine.2014.12.044 Full text not available from this repository.

Takeda, A; Cooper, K; Bird, A; Baxter, L; Frampton, GK; Gospodarevskaya, E; Welch, K; Bryant, J; (2010) Recombinant human growth hormone for the treatment of growth disorders in children: a systematic review and economic evaluation. Health technology assessment (Winchester, England), 14 (42). 1-209, iii-iv. ISSN 1366-5278 DOI: https://doi.org/10.3310/hta14420